Monday June 18, 2018

Study: Smoking During Pregnancy can Cause Hearing Loss in Baby

Children who were exposed to tobacco smoke during pregnancy and second-hand smoke at 4 months had a 2.4 times increased relative risk

0
//
28
Thyroid dysfunction may lead to diabetes during pregnancy
Thyroid dysfunction may lead to diabetes during pregnancy. Pixabay
Republish
Reprint

If you are planning to start motherhood, quit smoking, say researchers. Exposing your baby to tobacco smoke during pregnancy or after the birth may cause hearing impairment in them.

According to the researchers, babies who were exposed to smoking during pregnancy had a 68 per cent increased relative risk of developing hearing problems.

“This study clearly shows that preventing exposure to tobacco smoke during pregnancy and postnatally may reduce the risk of hearing problems in children,” said Koji Kawakami from the Kyoto University in Japan.

The study, published in the journal Pediatric and Perinatal Epidemiology, included data from 50,734 children aged 3 years.

Representational image.
Representational image. Pixabay

Out of the group, 3.8 per cent were exposed to smoking only during pregnancy, 3.9 per cent were exposed only to second-hand smoke at 4 months and 0.9 per cent were exposed to tobacco smoke during pregnancy and at 4 months.

The results showed that the prevalence of hearing impairment among babies aged three who were exposed to smoke was 4.6 per cent while those exposed to only second-hand smoke at 4 months had a 30 per cent increased relative risk.

Also Read: Research Shows Smoking Affects Leg Muscles

Children who were exposed to tobacco smoke during pregnancy and second-hand smoke at 4 months had a 2.4 times increased relative risk.

“The findings remind us of the need to continue strengthening interventions to prevent smoking before and during pregnancy and exposure to second-hand smoke in children,” Kawakami added. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Obesity And Smoking: Roadblocks In Arthritis Treatment

Rheumatoid arthritis is a chronic inflammatory disease

0
Obesity And Smoking Becomes Roadblocks In Arthritis Treatment
Obesity And Smoking Becomes Roadblocks In Arthritis Treatment, Pixabay

Obesity in women and smoking among men could be major factors behind not achieving remission in rheumatoid arthritis, despite early treatment, researchers say.

Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability and can also affect internal organs.

The study showed that though early identification and aggressive treatment improve arthritis outcomes, six per cent of women and 38 per cent of men did not achieve remission in the first year despite receiving guideline-based care.

“Our results suggest that lifestyle changes — smoking cessation in men and weight reduction in women — as well as optimising methotrexate use may facilitate rapid reduction of inflammation, an essential goal of treatment in early rheumatoid arthritis,” said Susan Bartlett, professor of Medicine at McGill University in Canada.

The study, published in the journal Annals of the Rheumatic Diseases, included 1,628 adults with an average age of 55.

The analysis highlighted that obesity more than doubled the likelihood of not achieving remission in women.

obesity
obesity, Pixabay

In men, current smoking was associated with 3.5 greater odds of not achieving remission within the first year.

Further, almost all patients within the study were initially treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with three quarters being treated with methotrexate.

Analysis demonstrated that not using methotrexate significantly increased the likelihood of not achieving remission in women by 28 per cent and in men by 45 per cent.

Also read: drug free compound can ease arthritis pain

“These results highlight the need to support physicians and empower patients to take advantage of the impact lifestyle changes can have on disease progression,” Johannes Bijlsma, President, European League Against Rheumatism (EULAR), said in a statement. (IANS)

Next Story